His Disease study falls within the topics of Reflux and Inflammatory bowel disease. His research on Inflammatory bowel disease often connects related areas such as Disease. His research on Internal medicine often connects related areas such as Logistic regression. He conducts interdisciplinary study in the fields of Cancer and Nuclear medicine through his research. In his research, he performs multidisciplinary study on Nuclear medicine and Cancer. Much of his study explores Surgery relationship to Randomized controlled trial. His research brings together the fields of Surgery and Randomized controlled trial. Peter D. Siersema integrates many fields in his works, including Gastroenterology and Endoscopy. In his study, he carries out multidisciplinary Endoscopy and Gastroenterology research.
Internal medicine and Pathology are two areas of study in which Peter D. Siersema engages in interdisciplinary research. Peter D. Siersema performs integrative Pathology and Internal medicine research in his work. In his research, Peter D. Siersema performs multidisciplinary study on Cancer and Colorectal cancer. He conducts interdisciplinary study in the fields of Colorectal cancer and Cancer through his works. His multidisciplinary approach integrates Surgery and Stent in his work. He combines Esophagus and Esophageal cancer in his research. In his works, he undertakes multidisciplinary study on Esophageal cancer and Esophagus. His Reflux research extends to the thematically linked field of Disease. His work in Reflux is not limited to one particular discipline; it also encompasses Disease.
In his study, Aerobic exercise and Clinical Practice is strongly linked to Physical therapy, which falls under the umbrella field of Cardiorespiratory fitness. His Surgery study frequently draws connections to other fields, such as CLIPS. Internal medicine is closely attributed to Logistic regression in his research. Logistic regression is closely attributed to Internal medicine in his work. He integrates several fields in his works, including Cancer and Adenocarcinoma. Peter D. Siersema performs multidisciplinary studies into Adenocarcinoma and Cancer in his work. Peter D. Siersema undertakes interdisciplinary study in the fields of Randomized controlled trial and Meta-analysis through his works. Peter D. Siersema integrates several fields in his works, including Meta-analysis and Randomized controlled trial. In his research, Peter D. Siersema performs multidisciplinary study on Colorectal cancer and Adenoma.
His research on Internal medicine often connects related topics like Logistic regression. His Logistic regression study typically links adjacent topics like Internal medicine. Surgery is closely attributed to Survival rate in his study. The study of Survival rate is intertwined with the study of Surgery in a number of ways. His work often combines Cancer and Adenocarcinoma studies. Peter D. Siersema incorporates Adenocarcinoma and Cancer in his studies. Chemoradiotherapy and Breast cancer are two areas of study in which he engages in interdisciplinary work. His Breast cancer study frequently draws connections between adjacent fields such as Neoadjuvant therapy. Peter D. Siersema combines Neoadjuvant therapy and Chemoradiotherapy in his research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium.
Toshiro Sato;Daniel E. Stange;Marc Ferrante;Marc Ferrante;Robert G.J. Vries.
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
Raffaella M Gadaleta;Karel J van Erpecum;Bas Oldenburg;Ellen C L Willemsen.
Staging investigations for oesophageal cancer: a meta-analysis
E P M van Vliet;M H Heijenbrok-Kal;M G M Hunink;E J Kuipers.
British Journal of Cancer (2008)
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial
Marjolein Y V Homs;Ewout W Steyerberg;Wilhelmina M H Eijkenboom;Hugo W Tilanus.
The Lancet (2004)
Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study
Mirthe Emilie van der Valk;Marie-Josée J Mangen;Max Leenders;Gerard Dijkstra.
Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.
Maurice W M D Lutgens;Martijn G H van Oijen;Geert J M G van der Heijden;Frank P Vleggaar.
Inflammatory Bowel Diseases (2013)
Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction
Marinke Westerterp;Linetta B. Koppert;Christianne J. Buskens;Hugo W. Tilanus.
Virchows Archiv (2005)
High lifetime risk of cancer in primary sclerosing cholangitis
Marian M.H. Claessen;Frank P. Vleggaar;Kristien M.A.J. Tytgat;Peter D. Siersema.
Journal of Hepatology (2009)
Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial.
Suzanne M. Jeurnink;Ewout W. Steyerberg;Jeanin E. van Hooft;Casper H.J. van Eijck.
Gastrointestinal Endoscopy (2010)
Increasing incidence of Barrett’s oesophagus in the general population
E.M. van Soest;Jeanne Dieleman;Peter Siersema;Miriam Sturkenboom.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: